Skip to Main Content
Skip Nav Destination

Issues

Journal Name Change

Vol. 1-78 (1893-1938) were published under the journal's former title Dermatologische Zeitschrift and Vol. 79-183 (1939-1991) under Dermatologica.

Dermatology 2023, Vol. 239, No. 3

Review Article

Dermatology (2023) 239 (3): 323–327. https://doi.org/10.1159/000529848
Dermatology (2023) 239 (3): 328–333. https://doi.org/10.1159/000529218

Innate immunity and innate cytokines seem to play a crucial role in AGEP pathogenesis.

Methods

Dermatology (2023) 239 (3): 334–344. https://doi.org/10.1159/000529398

Research Article

Dermatology (2023) 239 (3): 345–354. https://doi.org/10.1159/000529274
Dermatology (2023) 239 (3): 355–361. https://doi.org/10.1159/000529964
Dermatology (2023) 239 (3): 362–367. https://doi.org/10.1159/000528968

This study shows the external validity of the novel IHS4-55 by demonstrating a significant association between IHS4-55 achievement and a reduction in inflammatory lesion counts as well as achievement of MCIDs for DLQI, NRS Pain, and NRS Pruritus in an antibiotics-treated cohort.

Dermatology (2023) 239 (3): 368–378. https://doi.org/10.1159/000528822

■■■

Dermatology (2023) 239 (3): 379–386. https://doi.org/10.1159/000529219

We performed the first study that investigates common benign skin tumors of the visible skin and their associations with sun-related behavior among the elderly.

Skin Cancer – Research Article

Dermatology (2023) 239 (3): 387–392. https://doi.org/10.1159/000529368

Selection of participants in a keratinocyte cancer prevention initiative is cost-effective by better directing resources to high-risk individuals.

Dermatology (2023) 239 (3): 393–402. https://doi.org/10.1159/000529369

KC development is strongly associated with AK in SOTRs.

Dermatology (2023) 239 (3): 403–408. https://doi.org/10.1159/000529847
Dermatology (2023) 239 (3): 409–421. https://doi.org/10.1159/000528159

BRAFV600E expression in melanoma predicts better prognosis.

Dermatology (2023) 239 (3): 422–428. https://doi.org/10.1159/000528555

Advanced cutaneous squamous cell carcinoma represents an unmet clinical need, with a heterogeneous treatment landscape.

Dermatology (2023) 239 (3): 429–435. https://doi.org/10.1159/000529367

The aim of the study was to report real-life management of incompletely excised BCC comparison of recurrence rates according to the selected treatment.

Dermoscopy and Clinical Imaging – Research Article

Dermatology (2023) 239 (3): 436–444. https://doi.org/10.1159/000529113

Morphology of vessels of cutaneous melanomas is associated with Breslow index, ulceration, and dermoscopic regression.

Outcome Measures – Research Article

Dermatology (2023) 239 (3): 445–453. https://doi.org/10.1159/000529194

Current study shows high internalized stigma in patients with HS which might be the leading cause of disease burden.

Skin Infections – Research Article

Dermatology (2023) 239 (3): 454–461. https://doi.org/10.1159/000529301

Patients affected by FD have an altered microbiome – immunity dialogue.

Wounds and Healing – Review Article

Dermatology (2023) 239 (3): 462–477. https://doi.org/10.1159/000529220

Incomplete reporting and substantial heterogeneity exist on the intralesional corticosteroid treatment in keloids among current randomized controlled trials.

Tattoo and Body Art – Research Article

Dermatology (2023) 239 (3): 478–493. https://doi.org/10.1159/000529577

Brief Report

Dermatology (2023) 239 (3): 494–498. https://doi.org/10.1159/000530108

or Create an Account

Close Modal
Close Modal